Skip to main content
Signal8

Minerva Surgical, Inc. (UTRS)

Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.

Sector: Medical - Devices

Industry: Medical - Devices

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

OTC:UTRSHealthcare
CLOSED
Mkt Cap-
EV-
Float961K
O/S8.88M
VOL260 sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 961.31K · FMP free float

102
Oct 30 (18d)prev 102– 0.0%
11.33
Oct 30 (18d)prev 17.00▼ 33.4%
Borrow (IBKR)

The cost to borrow UTRS shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 2026102 sh
Oct 15, 2026102 sh
Sep 30, 2026102 sh
Sep 15, 2026102 sh
Aug 31, 2026102 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for UTRS: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 102 UTRS shares were sold short (0.01% of a 961K-share float, 11.33 days to cover).